We are live on ! Find out more
COCH icon

Envoy Medical

9 hedge funds and large institutions have $3.02M invested in Envoy Medical in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% less funds holding

Funds holding: 169 (-7)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

61.25% less ownership

Funds ownership: 69.68%8.44% (-61%)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

88% less capital invested

Capital invested by funds: $24.9M → $3.02M (-$21.9M)

Holders
9
Holders Change
-7
Holders Change %
-43.75%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
2
Closed
10
Calls
Puts
Net Calls
Net Calls Change

COCH Hedge Fund Activity: Q4 2023 in Review

9 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2023, worth a combined $3.02M — down 88% from $24.9M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of COCH and 3 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Geode Capital Management, adding an estimated $83.6K. The largest seller was Sandia Investment Management, exiting entirely with an estimated $5.21M sold.

  • 9 institutional investors held Envoy Medical (COCH) as of Q4 2023, down from 16 in Q3 2023.
  • Funds reported $3.02M of Envoy Medical stock for Q4 2023, down 88% quarter-over-quarter.
  • 3 funds opened new Envoy Medical positions in Q4 2023 and 10 closed out, a net change of -7 holders.
  • The largest Envoy Medical buyer in Q4 2023 was Geode Capital Management, an estimated $83.6K added.
  • The largest Envoy Medical seller in Q4 2023 was Sandia Investment Management, an estimated $5.21M sold.

Based on aggregated 13F filings for Q4 2023.